Novo Nordisk has an appetite for more acquisitions
Novo Nordisk has made a number of acquisitions in recent years, and more may be on the way, according to Chief Scientific Officer at Novo Nordisk Marcus Schindler to Danish business daily Børsen.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Secretive company receives DKK 30m from Novo Holdings
For subscribers
Novo Nordisk sues US pharmacy to block knock-off
For subscribers